A cancer clinical trial can open the door to a treatment that is not otherwise available. For a patient with limited options, a rare cancer or a disease that has stopped responding to standard treatment, that opportunity can be enormously important.
But there is a financial question that deserves attention before enrollment:
What will participating in the trial actually cost you?
The answer is often misunderstood.
The experimental drug or procedure may be provided by the study sponsor. Some research-related testing may also be covered. Health insurance may pay for much of the routine medical care a patient would have received anyway.
Yet a patient can still face airfare, hotels, meals, parking, repeated trips to the study site, childcare, time away from work and medical expenses that fall outside the trial.
The National Cancer Institute specifically advises patients to ask which expenses the study covers and which expenses remain the responsibility of the patient or the patient’s health plan.
For someone considering a trial far from home, understanding that distinction early can prevent an unexpected financial problem after treatment has already begun.
The First Question: Who Pays for the Treatment Being Studied?
Clinical trial expenses generally fall into two categories: research costs and patient-care costs.
Research costs exist specifically because someone is participating in the study. According to the National Cancer Institute, these may include the study drug, laboratory tests performed only for research, additional imaging required by the study and extra medical visits that would not otherwise occur.
These costs are often covered by the organization sponsoring the trial rather than by the patient’s health insurance.
Patient-care costs are different.
These are medical expenses a patient could reasonably have even without participating in the study. They may include physician visits, hospital stays, standard cancer treatment, treatment for symptoms or side effects, laboratory testing and imaging.
Health insurance often covers these routine costs, subject to the patient’s normal policy requirements.
That means “the trial pays for treatment” can be an incomplete description.
A patient needs to know which parts of the treatment are considered research and which parts are considered ordinary medical care.
Insurance Can Still Matter During a Clinical Trial
Federal law requires most health plans to cover routine patient-care costs for qualifying clinical trials, according to the National Cancer Institute. Medicaid also covers routine patient-care costs in clinical trials, while Medicare provides coverage for certain costs associated with qualifying clinical research studies.
Coverage, however, does not necessarily mean a patient has no financial responsibility.
The usual terms of a health plan can still matter. Deductibles, copayments, coinsurance, provider networks and authorization requirements do not automatically disappear because the patient enters a clinical trial.
The National Cancer Institute recommends speaking with the research team and health plan before enrollment and determining whether preauthorization is required.
If an insurer requests documentation, that may include medical records, a physician letter explaining the trial and a copy of the informed-consent document.
This is worth doing before the first treatment whenever possible.
A clinical trial coordinator or hospital financial counselor may have dealt with the same insurer before and may know which documentation has been required for other participants.
The Hidden Cost May Be Getting to the Trial
For many patients, the most difficult clinical trial expense is not the treatment itself.
It is geography.
A trial may require treatment at a particular academic medical center several states away. Another may require repeated visits rather than one extended stay. Screening may occur on one trip, treatment on another and follow-up appointments over the following months.
The National Cancer Institute notes that trial participation can create expenses for travel, lodging, meals, parking, childcare and elder care. Some studies help with these costs, but not all do.
The time commitment can vary just as dramatically. The number of visits, location of the study and procedures required are different for every trial. Depending on the study, support may include transportation or lodging assistance, while some follow-up appointments may be possible through telehealth.
This is why the right financial question is not simply:
“Is the clinical trial free?”
A much better question is:
“What expenses should I expect over the entire time I am participating?”
A Trial at NIH Shows Why the Details Matter
Clinical trials conducted at the National Institutes of Health Clinical Center provide a useful example.
For patients enrolled in trials through the National Cancer Institute’s Center for Cancer Research, medical care received at the NIH Clinical Center is provided without charge. This includes trial medications and hospital stays when necessary.
Travel and lodging assistance may also be available for patients who do not live locally.
That is substantial support.
Even there, however, patients are encouraged to maintain health insurance because medical care unrelated to the study may need to be provided outside the NIH Clinical Center.
Other National Cancer Institute programs illustrate another important distinction.
For some trials, patients are responsible for transportation to the initial screening visit. Once enrolled, eligible patients living outside the local area may receive transportation assistance for later trial-related visits and a modest allowance toward meals and lodging.
In other words, even within one major research institution, the financial arrangements can depend on the particular study.
Never assume that the financial policies of one clinical trial apply to another.
Screening Costs Deserve Their Own Question
Patients understandably focus on what happens after they are accepted into a trial.
But first they have to qualify.
Screening can involve medical-record review, laboratory testing, imaging, consultations or travel to the research center. A patient can go through that process and ultimately learn that the trial is not a match.
Before traveling, ask what the screening process requires and who pays for it.
If airfare and lodging are required, determine whether those expenses are reimbursed even if the patient does not ultimately enroll.
This can be especially important when a patient is considering more than one trial at different institutions.
Do Not Forget the Cost of Time
Some clinical trial expenses never appear on a hospital bill.
A patient may need to take unpaid leave from work. A spouse may accompany the patient and lose income as well. Children may need care during appointments. Pets may need boarding. A family traveling for an extended treatment period may temporarily be supporting expenses in two locations.
Those costs can matter even when the medical treatment itself is completely covered.
The National Cancer Institute recognizes that treatment trials may require more medical visits and tests than standard care and that the additional visits can create travel, housing and childcare expenses.
Patients should therefore look at the trial calendar before deciding whether participation is financially manageable.
Ask how often you will need to be physically present at the study site, how long visits typically last and whether any follow-up testing can be completed near home.
What to Ask Before You Enroll
A research coordinator should be able to help separate the different expenses.
Before signing the informed-consent paperwork, patients should understand whether the study sponsor pays for the experimental treatment, which tests are considered research-related, which services will be billed to insurance and what expenses remain out of pocket.
Travel requires its own discussion.
Ask whether the trial reimburses airfare, mileage, hotels, meals or parking. Find out whether assistance applies to a companion as well as the patient.
If reimbursement is available, ask whether the patient must pay first and submit receipts later.
Also ask how long reimbursement normally takes.
For a family already under financial pressure, having to advance several thousand dollars and wait for repayment can be very different from having travel booked directly by the study.
Financial Assistance Can Make a Trial More Reachable
If the study does not cover every expense, that does not necessarily mean the patient has to decline participation.
Ask the trial team whether the hospital has a financial navigator or social worker familiar with clinical trial assistance.
Some institutions have patient-assistance funds. Disease-specific organizations may offer transportation or lodging support. Nonprofit programs may help with certain household expenses. The research team may also know about resources used by previous participants.
These programs should be explored early.
There is no reason to leave available assistance unused simply because it will not cover every expense.
For a patient who needs to travel repeatedly, several smaller forms of support can collectively make a meaningful difference.
When the Remaining Financial Gap Is Still Large
Some patients will do everything above and still face a substantial cost.
This can happen when a trial requires extended travel, a temporary relocation, repeated cross-country visits or significant time away from work. It can also happen when a patient is pursuing treatment outside a clinical trial after exhausting standard options.
For a cancer patient who owns an individual life insurance policy, that policy may be a financial asset worth evaluating.
A viatical settlement allows a qualifying person with a serious illness to sell an existing life insurance policy for a cash payment while living. The buyer becomes responsible for the policy and ultimately receives the death benefit.
The proceeds are unrestricted.
That distinction can matter in the clinical trial setting because a patient may need money for expenses that insurance or the trial sponsor does not cover, including travel, temporary housing or ordinary household expenses while away from work.
Cancer Care Financial specializes in viatical settlements for cancer patients. An individual term, whole life or universal life insurance policy may potentially qualify.
A term policy should not be dismissed simply because it has no cash surrender value. It can still have value in the viatical market.
A policy review does not require the patient to accept an offer.
The purpose is to understand whether another financial resource exists before a patient makes a major treatment decision based on money alone.
A Clinical Trial Should Be Evaluated Medically and Financially
Clinical trials are research studies, not financial products. The medical questions always come first.
Is the patient eligible?
What is being studied?
What are the potential risks and benefits?
What alternatives are available?
But once a patient and oncology team believe a trial deserves serious consideration, the financial questions belong in the conversation too.
The most important thing to understand is that clinical trial treatment and clinical trial participation are not necessarily the same expense.
The sponsor may pay for the study drug. Insurance may cover routine care. A hospital may help with lodging. A nonprofit may assist with transportation.
The patient may still have costs left over.
Knowing exactly what those costs are before enrollment gives families time to use the resources available to them instead of discovering the financial gap halfway through treatment.
People Also Ask
Do cancer patients have to pay to participate in clinical trials?
Sometimes. Research-related costs, such as an experimental drug or testing performed solely for the study, are often covered by the study sponsor. Patients or their health insurance may still be responsible for routine medical care and other expenses associated with participation.
Does health insurance cover cancer clinical trials?
Most health plans are required to cover routine patient-care costs in qualifying clinical trials. Coverage can still be subject to the normal terms of the health plan, and patients should ask whether preauthorization is required before enrolling.
Who pays for travel to a cancer clinical trial?
It depends on the individual study. Some clinical trials provide transportation, lodging or other travel assistance, while others do not. Patients should ask the research coordinator specifically about travel reimbursement before enrolling.
Are cancer clinical trials at NIH free?
Medical care received by participants in clinical trials at the NIH Clinical Center is provided without charge. Eligible patients traveling from outside the local area may also receive assistance with travel and lodging, although the specific arrangements depend on the program and trial.
Does a clinical trial pay for hotels?
Some do. Lodging assistance varies by study and institution. Patients should ask whether the trial pays the hotel directly, provides a lodging allowance or requires the patient to pay first and request reimbursement later.
What happens if insurance denies coverage for routine care during a clinical trial?
The National Cancer Institute recommends contacting the insurance plan and working with the trial team or hospital billing staff on an appeal. Supporting information may include medical literature and a physician letter explaining why the trial is appropriate.
Can a viatical settlement help pay expenses related to a cancer clinical trial?
Potentially. A cancer patient with a qualifying individual life insurance policy may be able to sell the policy through a viatical settlement. The proceeds are unrestricted and can be used for expenses such as travel, lodging, living costs or other needs that arise while pursuing treatment.
